Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
REVENUES
Product revenue, net	$ 216,097	$ 88,741	$ 447,719	$ (363,790)
License and contract	0	0	250,000	0
Total revenues	216,097	88,741	697,719	(363,790)
OPERATING EXPENSES
Cost of products sold	46,908	55,440	130,012	110,040
Research and development	4,980,074	2,509,490	13,891,235	9,444,759
Selling, general and administrative	3,009,528	4,010,055	10,163,830	11,386,574
Gain on license termination agreement	0	0	0	(1,623,795)
Total operating expenses	8,036,510	6,574,985	24,185,077	19,317,578
Loss from operations	(7,820,413)	(6,486,244)	(23,487,358)	(19,681,368)
OTHER INCOME (EXPENSE)
Investment income	1,127	2,834	4,100	19,769
Foreign currency gain	190,719	753,750	64,000	8,748
Interest expense	(3,019)	0	(11,423)	(9,360)
Total other income, net	188,827	756,584	56,677	19,157
NET LOSS	$ (7,631,586)	$ (5,729,660)	$ (23,430,681)	$ (19,662,211)
Basic and diluted net loss per common share	$ (0.03)	$ (0.02)	$ (0.10)	$ (0.08)
Weighted average number of common shares outstanding used in computing basic and diluted net loss per common share	238,805,370	236,832,283	238,444,206	236,525,514